Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Mapping the crystallization landscape of rare earth MOFs: a high-throughput investigation of structure, kinetics, and selectivity.

Chemical science·2026
Same author

Integrating AI and Causal Genetics to Prioritize Therapeutic Targets for Aging and Age-Related Diseases.

Aging and disease·2026
Same author

Quantitative prediction of siRNA complexation by ionizable drugs enables their codelivery in nanoparticles.

Science advances·2026
Same author

Novel drug targets in 2025.

Nature reviews. Drug discovery·2026
Same author

Photochemical post-functionalization of polystyrene enables accelerated chemical recycling.

Chemical science·2026
Same author

An oncostatin M receptor and chloride intracellular channel 1 crosstalk drives key oncogenic pathways in glioblastoma.

Signal transduction and targeted therapy·2026
Same journal

Unlocking the chemical potential of filamentous fungi using prime editing.

Nature biotechnology·2026
Same journal

A genome-scale CRISPRi perturbation atlas of human induced pluripotent stem cells.

Nature biotechnology·2026
Same journal

Prime editing for precise genome engineering and modulation of fungal metabolism.

Nature biotechnology·2026
Same journal

Retargeted serine integrases for one-step, precise integration of large DNA sequences in human cells.

Nature biotechnology·2026
Same journal

A retargeted recombinase for precise insertion of large DNA.

Nature biotechnology·2026
Same journal

Experiment-guided AlphaFold3 resolves measurement-consistent protein ensembles.

Nature biotechnology·2026
查看所有相关文章

相关实验视频

Updated: Jun 9, 2026

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

14.8K

量子计算增强的算法揭示了潜在的KRAS抑制剂.

Mohammad Ghazi Vakili1,2, Christoph Gorgulla3,4, Jamie Snider5

  • 1Department of Computer Science, University of Toronto, Toronto, Ontario, Canada.

Nature biotechnology
|January 22, 2025
PubMed
概括
此摘要是机器生成的。

我们开发了一种量子经典模型,用于设计用于癌症治疗的KRAS抑制剂. 这种方法产生了15个潜在的分子,其中两个显示未来药物开发的希望.

更多相关视频

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.5K
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

17.8K

相关实验视频

Last Updated: Jun 9, 2026

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

14.8K
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.5K
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

17.8K

科学领域:

  • 量子计算在药物发现中的应用.
  • 用于药物化学的计算化学.
  • 瘤学治疗的开发方法

背景情况:

  • 针对KRAS对于癌症治疗至关重要,但开发有效的抑制剂仍然具有挑战性.
  • 经典的计算方法在探索药物设计的新化学空间方面存在局限性.
  • 量子经典方法为分子设计提供了一个新的范式.

研究的目的:

  • 引入和应用一个新的量子经典生成模型用于小分子设计.
  • 专门针对癌症治疗的KRAS抑制剂的设计.
  • 通过实验合成和测试来验证模型的有效性.

主要方法:

  • 开发一个混合量子-经典生成算法.
  • 模型的应用以识别潜在的KRAS参与的小分子.
  • 在选和随后的15个候选分子的实验合成.

主要成果:

  • 量子经典模型成功设计了15种新的小分子.
  • 两个合成的分子与KRAS显著参与.
  • 实验验证证证实了该模型产生有前途的候选药物的能力.

结论:

  • 量子经典生成模型显示了加速药物发现的巨大潜力.
  • 这项工作验证了量子计算在产生实验相关的小分子中的使用.
  • 开发的方法为设计向癌症治疗的经典模型提供了有竞争力的替代方案.